{"id":972088,"date":"2026-06-15T09:19:44","date_gmt":"2026-06-15T13:19:44","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/wiley-and-iqvia-release-cross-sector-report-on-ais-promise-and-pressure-points-across-healthcare-value-chain\/"},"modified":"2026-06-15T09:19:44","modified_gmt":"2026-06-15T13:19:44","slug":"wiley-and-iqvia-release-cross-sector-report-on-ais-promise-and-pressure-points-across-healthcare-value-chain","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/wiley-and-iqvia-release-cross-sector-report-on-ais-promise-and-pressure-points-across-healthcare-value-chain\/","title":{"rendered":"Wiley and IQVIA Release Cross-Sector Report on AI\u2019s Promise and Pressure Points Across Healthcare Value Chain"},"content":{"rendered":"

<\/p>\n

Wiley and IQVIA Release Cross-Sector Report on AI\u2019s Promise and Pressure Points Across Healthcare Value Chain<\/b><\/p>\n

Insights drawn from executive Summit hosted by Wiley and IQVIA with leaders from pharma, academia, health systems, technology companies and more<\/i><\/p>\n

HOBOKEN, N.J.–(BUSINESS WIRE<\/a>)–
\nWiley (NYSE: WLY) and IQVIA (NYSE: IQV) today released Scientific Discovery & AI: The Science-to-Patient Journey<\/i><\/a>, a cross-sector intelligence report drawing on candid dialogue among more than 25 senior leaders from pharma R&D, academic medicine, health systems, AI and technology, publishing and learned societies.<\/p>\n

This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20260615344569\/en\/<\/a><\/p>\n

\"\"<\/div>\n

\nThe report summarizes insights from The Summit \u2014 an invitation-only, two-day working session co-hosted by Wiley and IQVIA in May 2026. The session opened with a forward-looking perspective on AI and organizational change from Ethan Mollick, Wharton professor, NYT bestselling author of Co-Intelligence<\/i>, and the forthcoming Co-Existence <\/i>(October 2026), which set the tone for the dynamic days of discussion. Participants included senior leaders from organizations such as Novo Nordisk, Microsoft, Amazon, Salesforce, American Association for the Advancement of Science (AAAS), American Heart Association, JAMA Network, Johns Hopkins University, University of Michigan, Map\u00faa University, South Dakota State University, American Society of Mechanical Engineers (ASME), BMJ Group, Japan Advanced Institute of Science and Technology, Queen Mary Intellectual Property Research Institute and Turbine.<\/p>\n

\nA key focus of the report is the gap between AI’s technical capability and the health system’s ability to absorb it. AI is accelerating every stage of the journey from scientific discovery to patient benefit \u2014 but acceleration at one stage can create fracture at the next. Examining each stage of the science-to-patient value chain, participants identified five high-potential directions for the ecosystem:<\/p>\n